Mt Carmel Hospital Gynecologic Oncology

Topics

• Endometrial and Cervical Cancer Treatments 272
• Ovarian cancer diagnosis and treatment 194
• PARP inhibition in cancer therapy 66
• Genetic factors in colorectal cancer 36
• Uterine Myomas and Treatments 18
• Cervical Cancer and HPV Research 16
• Intraperitoneal and Appendiceal Malignancies 14
• BRCA gene mutations in cancer 11
• Cancer Risks and Factors 9
• Economic and Financial Impacts of Cancer 9
• Extracellular vesicles in disease 9
• Gestational Trophoblastic Disease Studies 9

Most cited

1. Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.

   The New England journal of medicine · 2023 · 703 citations · Larry Copeland

2. Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 486 citations · Christa Nagel

3. Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.

   The New England journal of medicine · 2023 · 633 citations · Floor Backes

4. NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 349 citations · Christa Nagel

5. Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.

   The New England journal of medicine · 2023 · 405 citations · Casey Cosgrove

6. Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2021 · 587 citations · David O'Malley

7. NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022.